Skye Bioscience, Inc. (SKYE) › EPS (Diluted)Skye Bioscience, Inc. (SKYE) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2016: $-0.172017: $-0.112018: $-0.162019: $-0.052020: $-0.032021: $-0.022022: $-8.772023: $-5.372024: $-0.732025: $-1.41$-1.412016EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$-1.41-93.2%2024$-0.73+86.4%2023$-5.37+38.8%2022$-8.77-43750.0%2021$-0.02+33.3%2020$-0.03+40.0%2019$-0.05+68.8%2018$-0.16-45.5%2017$-0.11+35.3%2016$-0.17—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share